GlassScriptPhysician profile
Harvey N Lisgar
NPI 1316929078
$7,534.26
in general payments reported to CMS, 2019-2025
47 companies · $284 in 2025
The $284 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $818 · 2020: $1,331 · 2021: $1,395 · 2022: $766 · 2023: $1,500 · 2024: $1,440 · 2025: $284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,222 · Education: $0.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,222.33 |
| Education | $0.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,178.05 | 2020-2025 | |
| Lilly USA, LLC | $749.00 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $667.36 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $654.58 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $542.38 | 2019-2025 | Farxiga, Airsupra |
| Novo Nordisk INC | $529.65 | 2019-2025 | Wegovy |
| Takeda Pharmaceuticals U.S.A., INC. | $334.62 | 2019-2023 | Trintellix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $189.42 | 2021-2024 | Jardiance |
| Allergan, INC. | $170.77 | 2019-2020 | |
| Exact Sciences Corporation | $143.84 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Merck Sharp & Dohme LLC | $138.38 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $135.46 | 2019-2023 | Seglentis, Livalo |
| Astellas Pharma US INC | $129.06 | 2023-2024 | Veozah |
| Janssen Pharmaceuticals, INC | $127.57 | 2019-2024 | Spravato |
| Amarin Pharma, INC. | $126.20 | 2019-2022 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harvey Lisgar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.